Showing results (211-220 of 233) with videos related to

Sort By:
Pageof 24
JAMA|September 15, 1975
Hypertension and unilateral parenchymal renal disease. Evidence for abnormal vasoconstriction-volume interactionE D Vaughan, F R Bühler, J H Laragh, et al.
International Journal of Cardiology|July 1, 1989
Effect of arginine vasopressin on coronary and systemic hemodynamics in manJ J Glazier, D P Faxon, R M Mills, et al.
Genomics|February 13, 2001
Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human lociF Sugiyama, G A Churchill, D C Higgins, et al.
Biochimica Et Biophysica Acta|May 22, 1990
High level of expression of functional human platelet alpha 2-adrenergic receptors in a stable mouse C127 cell lineM R Bresnahan, C S Flordellis, D K Vassilatis, et al.
American Heart Journal|May 1, 1981
Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapyD P Faxon, J L Halperin, M A Creager, et al.
British Journal of Clinical Pharmacology|December 1, 1981
RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteersM Burnier, G A Turini, H R Brunner, et al.
The American Journal of Physiology|February 1, 1984
Effect of renin-angiotensin system on limb circulation in normal subjectsM A Creager, D P Faxon, S M Rockwell, et al.
The American Journal of Physiology|February 1, 1996
Effects of vasopressin V1-receptor blockade during acute and sustained hypovolemic hypotensionB M Wall, K M Huch, K R Runyan, et al.
The American Journal of Physiology|January 1, 1984
Does vasopressin sustain blood pressure of normally hydrated healthy volunteers?J P Bussien, B Waeber, J Nussberger, et al.
International Journal of Cardiology|January 1, 1982
The effect of angiotensin converting enzyme inhibition of coronary blood flow and hemodynamics in patients without coronary artery diseaseD P Faxon, M A Creager, J L Halperin, et al.
Pageof 24